- Home
- MGOL vs DOMH Comparison
MGOL vs DOMH Comparison
Compare MGOL & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGOL
- DOMH
- Stock Information
- Founded
- MGOL 2018
- DOMH 1967
- Country
- MGOL United States
- DOMH United States
- Employees
- MGOL N/A
- DOMH N/A
- Industry
- MGOL Advertising
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- MGOL Consumer Discretionary
- DOMH Health Care
- Exchange
- MGOL Nasdaq
- DOMH Nasdaq
- Market Cap
- MGOL 7.3M
- DOMH 7.3M
- IPO Year
- MGOL 2023
- DOMH N/A
- Fundamental
- Price
- MGOL $0.58
- DOMH $1.23
- Analyst Decision
- MGOL
- DOMH
- Analyst Count
- MGOL 0
- DOMH 0
- Target Price
- MGOL N/A
- DOMH N/A
- AVG Volume (30 Days)
- MGOL 6.0M
- DOMH 68.6K
- Earning Date
- MGOL 11-14-2024
- DOMH 11-08-2024
- Dividend Yield
- MGOL N/A
- DOMH N/A
- EPS Growth
- MGOL N/A
- DOMH N/A
- EPS
- MGOL N/A
- DOMH N/A
- Revenue
- MGOL $5,197,527.00
- DOMH $12,589,000.00
- Revenue This Year
- MGOL N/A
- DOMH N/A
- Revenue Next Year
- MGOL N/A
- DOMH N/A
- P/E Ratio
- MGOL N/A
- DOMH N/A
- Revenue Growth
- MGOL 47.01
- DOMH 1117.50
- 52 Week Low
- MGOL $0.36
- DOMH $0.83
- 52 Week High
- MGOL $18.30
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- MGOL 26.07
- DOMH 49.20
- Support Level
- MGOL $0.51
- DOMH $1.00
- Resistance Level
- MGOL $0.66
- DOMH $1.29
- Average True Range (ATR)
- MGOL 0.11
- DOMH 0.14
- MACD
- MGOL 0.06
- DOMH 0.02
- Stochastic Oscillator
- MGOL 37.75
- DOMH 86.96
About MGOL MGO Global Inc.
MGO Global Inc has built a brand acceleration platform with a focus on the acquisition, optimization and monetization of consumer brands across multiple categories. Its mission is to provide customers with unmatched variety, quality and shopping experience. The Company has three reportable segments: 1) The Messi Store, which sells a range of products under The Messi Brand; 2) Stand Flagpoles, which sells a range of residential flagpoles and related products direct to consumers; and 3) Corporate, which generates no revenue, but reflects corporate expenses related primarily to being a public company.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.